8-K: Surmodics, Inc. Announces Results of Annual Shareholder Meeting

Surmodics, Inc. held its annual shareholder meeting on February 6, 2025, and shareholders voted on the election of a director, setting the number of directors, ratification of the appointment of Deloitte & Touche LLP, and an advisory vote on executive compensation.

Summary

• Surmodics, Inc. held its Annual Meeting of Shareholders on February 6, 2025.
• Shareholders elected Gary R. Maharaj as a Class II director with 8,404,069 votes for, 187,820 votes withheld, and 1,908,890 broker non-votes.
• The proposal to set the number of directors at five (5) was approved with 10,441,062 votes for, 59,413 votes against, and 304 abstentions.
• The appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for fiscal year 2025 was ratified with 10,463,759 votes for, 35,348 votes against, and 1,672 abstentions.
• An advisory vote on executive compensation was approved with 7,415,339 votes for, 1,043,557 votes against, 132,993 abstentions, and 1,908,890 broker non-votes.

Sentiment

Score: 7

Explanation: The document reports standard corporate governance matters, indicating a neutral to slightly positive sentiment due to the successful passage of all proposals.

Positives

• All proposals presented to shareholders were approved.

Industry Context

This announcement is a routine disclosure related to corporate governance and shareholder voting, which is standard practice for publicly traded companies.

Stakeholder Impact

• The election of the director and ratification of the accounting firm provide assurance to shareholders regarding the company's governance and financial oversight.
• The advisory vote on executive compensation allows shareholders to express their views on the company's pay practices.

Key Dates

Keywords

Annual Meeting, Shareholders, Director Election, Executive Compensation, Deloitte & Touche, Surmodics